OXON at CTS sharing a new method to boost trial and RWE study efficiency November 28-29, 2024 | Barcelona OXON will support CTS 2024 as an exhibitor, showcasing expanded services and new developments in RWE. OXON’s Epidemiology will be at the 9th Clinical Trial Summit in Barcelona to share how our Real-World Evidence (RWE)-driven clinical…
Read more
Evaluating ICDs’ Role in Reducing Sudden Cardiac Death Among High-Risk Patients OXON Epidemiology’s latest study, recently featured in JAMA Cardiology, provides critical insights into the effectiveness of implantable cardioverter-defibrillators (ICDs) compared to amiodarone in reducing sudden cardiac death among patients with chronic Chagas cardiomyopathy. Known as the CHAGASICS Randomized Clinical Trial, the study enrolled 323…
Read more
‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscape of Italy Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Thursday, 24 October 2024 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Carlo Giaquinto Professor of Paediatrics at the Department for Woman’s and Child’s Health of…
Read more
‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscape of France Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Thursday, 19 September 2024 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Patrick Blin Pharmaco-Epi Senior Consultant, SNDS expert and Vice-president of the Ethics and Scientific…
Read more
OXON’s new RWE services and developments at ISPE Annual Meeting August 24-28, 2024 | Estrel Congress Center | Berlin, Germany OXON will be supporting ICPE 2024 as an exhibitor, showcasing expanded services and new developments in RWE. We are excited to announce that OXON’s Epidemiology team will be presenting and exhibiting at the ISPE 2024…
Read more
OXON Real-World Evidence Alzheimer’s Research in 2024 Lancet Report We are excited to announce that OXON’s Real-World Evidence (RWE) Alzheimer’s research has been prominently cited in the 2024 Lancet Commission on Dementia Report. This prestigious recognition underscores our commitment to advancing Alzheimer’s research and improving patient outcomes through evidence-based insights. Significant Contribution The Lancet Commission…
Read more
‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscape of Japan Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Thursday, 11 July 2024 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Masao Iwagami Clinical Epidemiologist and Professor at the University of Tsukuba, and Honorary Assistant…
Read more
Free Live Online Masterclass RWE & Trials with Professor Stuart Pocock “External Controls for Trials: Strategy, Science, Regulators & HTAs” DATE: Tuesday, 11 June 2024, at 5pm CEST | 4pm UK time | 11am EST. Free Live Online Masterclass to learn about perspectives on external controls from an epidemiologist/clinician and eminent medical statistician, illustrated with…
Read more
‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscape of the UK Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Wednesday, 26 June 2024 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Tom MacDonald Professor of Clinical Pharmacology & Pharmacoepidemiology, University of Dundee, and Honorary…
Read more
OXON is proud to be a Gold Sponsor at the 16th Clinical Trials Strategic Summit (CTSS) May 28-29, 2024 | Munich Marriott Hotel | Munich, Germany The 16th Clinical Trials Strategic Summit (CTSS) serves as a hub where innovative ideas find pathways to practical implementation. The event features dynamic panel discussions with industry leaders, one-on-one…
Read more
